title: [Evaluation on effect of treatment and assistance to advanced schistosomiasis patients in Hunan Province from 2004 to 2013].
abstract: OBJECTIVE
  To comprehensively evaluate the effect of the program of treatment and assistance to advanced schistosomiasis patients in Hunan Province from 2004 to 2013.
  
  
  METHODS
  The fund investment of the program, the profits of hospitals and the improvement of the patients' health were investigated by data collection and questionnaire survey. The evaluation index system of treatment and assistance to advanced schistosomiasis in Hunan Province was constructed by the Delphi method and analytic hierarchy process, and the program was assessed comprehensively.
  
  
  RESULTS
  The evaluation index system including 6 primary indices and 33 secondary indices was established. Among all the primary indices, the score of the treatment and assistance (22.25) was the highest, and that of the satisfaction assessment (8.15) was the lowest, and the score of the comprehensive assessment was 87.06. The average cure rate of the patients was 13.08% from 2004 to 2013. More than 60% of the patients' disease condition got better, and nearly 70% of the patients' psychological condition improved, and more than 70% of patients' self-help ability and social contact improved, as well as family happiness increased. In addition, the annual average cost for caretakers decreased by 2000 Yuan, and the profits of all the fixed-point hospitals for treatment and assistance increased.
  
  
  CONCLUSIONS
  The effectiveness and efficiency of the treatment and assistance to advanced schistosomiasis patients in Hunan Province is obvious, and the government should continuously invest in the program.
authors.forename: Sheng-ming
authors.initials: SM
authors.lastname: Li
authors.forename: Zheng-yuan
authors.initials: ZY
authors.lastname: Zhao
authors.forename: Zai-zhi
authors.initials: ZZ
authors.lastname: Peng
authors.forename: Zhang-hua
authors.initials: ZH
authors.lastname: Wang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Li
authors.forename: Feng-ying
authors.initials: FY
authors.lastname: Guo
authors.forename: Guang-hui
authors.initials: GH
authors.lastname: Ren
mesh_terms: D002681:China / Q000453:epidemiology; D006801:Humans; D011785:Quality Assurance, Health Care; D012552:Schistosomiasis / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D016896:Treatment Outcome